<DOC>
	<DOCNO>NCT00003811</DOCNO>
	<brief_summary>RATIONALE : Chemotherapy drug use different way stop tumor cell divide stop grow die . Chemoprotective drug amifostine may protect normal cell side effect chemotherapy . PURPOSE : Phase I trial study effectiveness high-dose cisplatin , etoposide , bleomycin plus amifostine treating child malignant germ cell tumor .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Amifostine Treating Children With Malignant Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate early efficacy toxicity profile high-dose cisplatin , etoposide , bleomycin , amifostine child newly diagnose , high-risk malignant , extragonadal germ cell tumor . II . Determine whether use amifostine reduce hematologic nonhematologic toxic effect combination chemotherapy patient compare similar patient treat POG-9049/CCG-8881 combination chemotherapy . III . Determine response rate patient treat regimen . OUTLINE : Patients undergo surgical biopsy resection . Patients receive bleomycin IV 10 minute day 1 etoposide IV 1 hour , amifostine IV 15 minute , cisplatin IV 1 hour day 1-5 . Treatment repeat every 3-4 week 4 course absence unacceptable toxicity disease progression . Patients disease 4 course chemotherapy receive treatment . Patients residual disease undergo second-look surgery . After surgery , patient still active tumor receive 2 additional course chemotherapy . Those patient still tumor 2 additional course may third surgery . Patients follow every month 6 month , every 2 month 6 month , every 6 month 1 year , annually thereafter death . PROJECTED ACCRUAL : A total 25 patient accrue study within 1.39 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Bleomycin</mesh_term>
	<mesh_term>Amifostine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , newly diagnose , highrisk , extracranial germ cell tumor include follow : Yolk sac carcinoma ( endodermal sinus tumor ) Embryonal carcinoma Choriocarcinoma Teratoma mixed malignant element ( malignant teratoma ) OR Malignant recurrence ( stage III IV ) previously resect stage I extracranial , extragonadal tumor Highrisk disease define stage III IV extragonadal tumor Measurable disease diagnostic imaging PATIENT CHARACTERISTICS : Age : Under 15 time diagnosis Performance status : Not specify Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 750/mm3 Platelet count great 75,000/mm3 Hepatic : Not specify Renal : Creatinine normal OR Glomerular filtration rate least 50 % normal PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>drug/agent toxicity tissue/organ</keyword>
	<keyword>childhood teratoma</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood extragonadal germ cell tumor</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
</DOC>